Understanding Atrial Fibrillation and Wearable Detection
Atrial fibrillation (AFib) represents one of the most common cardiac arrhythmias affecting millions worldwide, characterized by irregular and often rapid heart rhythms that can lead to serious complications including…
Jakob Wollborn, M.D., M.P.H., Cardiothoracic Anesthesiologist and Intensivist at Brigham and Women’s Hospital
Atrial fibrillation, or AFib, is one of the most common complications following cardiac surgery. It affects up to 40% of patients, depending…
Continue Reading
Circular, maker of smart ring technology, announced its next-generation wearable, the Ring 2, which includes ECG capability with its FDA-cleared AFib detection algorithm that provides real-time heart health data to wearers. The titanium Ring 2…
Continue Reading
Welcome to the May edition of Digital Health Digest!This month, we're spotlighting key developments in telehealth funding, weight loss programs, cybersecurity challenges, and advancements in wearable technology. Join us to explore how these innovations…
Continue Reading
What You Should Know:
– WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in ambulatory cardiac monitoring.
– The acquisition, coupled with a recent $6.7M…
Continue Reading
Despite being the most common form of cardiac arrhythmia, atrial fibrillation (AFib) is a condition that often goes undiagnosed and/or untreated. The condition, which often accompanies other health problems like hypertension and heart failure,…
Continue Reading
Kansas City-based Saint Luke’s Mid America Heart Institute is partnering with virtual specialty care company Story Health to co-develop an atrial fibrillation (AFib) program for the health system’s patients. The program, which will be rolled…
Continue Reading
What You Should Know:
– Saint Luke’s Mid America Heart Institute today launched the newest solution on its care platform, a comprehensive program to support patients living with or at risk of developing Atrial Fibrillation…
Continue Reading
A new artificial intelligence approach developed by investigators in Cedars-Sinai’s Los Angeles-based Smidt Heart Institute has been shown to detect abnormal heart rhythms associated with atrial fibrillation that might otherwise be unnoticed by physicians.WHY…
Continue Reading
The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, enabling researchers to use it to detect arrhythmias or…
Continue Reading
